Skip to content
Johnson Pharmacare logo

Johnson Pharmacare

532154 BSE
₹0.40 unchanged 0.00 (0.00%)
Market Cap
₹22.05 Cr

Johnson Pharmacare (JOHNPHARMA) share price was ₹0.40 at the 28 Oct 2026 close; market capitalisation ₹22.05 Cr; sector Commercial Services. The share price fell 39.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was −₹1.10 Cr, against −₹0.05 Cr a year earlier (compared with Jun 2025). Promoters held 0.00% of Johnson Pharmacare in Jun 2026, unchanged from Mar 2026. Its Tapetide Score is 27/100 (Poor) as of 28 Oct 2026.

Close 28 Oct 2026 ₹0.40 −0.25 −38.46% 1Y

Key Fundamentals

MicrocapCommercial ServicesServices
Market Cap
₹22.05 Cr
EBITDA
−₹57.05 Cr
Return on Equity
-1.04%
Debt to Equity
0.02
Book Value
₹0.01
EPS (TTM)
−₹1.03
52W High
₹0.70
52W Low
₹0.37

Price-based figures as of 29 Oct 2026, 10:42 IST · EPS basis: Standalone · TTM

Peer Comparison

Services › Commercial Services › Diversified Services › Diversified Commercial Services

International Gemological Institute
₹405.7528.7617,535 Cr10.020.65%47.80%58.83%1,521 Cr611 Cr
WeWork India Management
₹639.05104.938,875 Cr26.070.00%64.94%11.08%2,850 Cr82 Cr
Indiabulls
₹31.5716.977,363 Cr2.070.00%11.14%6.24%1,121 Cr488 Cr
Nesco
₹1,003.4016.977,070 Cr2.240.71%13.77%15.50%1,055 Cr417 Cr
Nirlon
₹630.0515.915,678 Cr12.124.76%73.83%23.30%689 Cr357 Cr
Leap India
₹119.10—5,247 Cr3.470.00%6.19%9.00%821 Cr75 Cr
Johnson Pharmacare (this company)
₹0.40—22 Cr40.000.00%-1.04%-1.03%2 Cr-57 Cr
Median 7 companies₹405.7516.977,070 Cr10.020.00%13.77%11.08%1,055 Cr357 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

27 Poor
Overall score

Data confidence 77/100

Category scores

Quality Poor 22
Returns, margins, earnings quality 24% weight
Valuation Poor 17
Cheap vs sector & own history 26% weight
Financial Health Poor 1
Solvency, leverage, coverage 10% weight
Momentum Poor 20
Trend strength, vol-adjusted 13% weight
Ownership Average 50
FII/DII/promoter flows 26% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

3
  • Stock is trading at 55.0 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -29.6% over last 3 years.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

Bearish

Bearish
12
Neutral
6
Bullish
1

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
—

Cash Flow Change
—

EBITDA Margin Change
100%

vs previous quarter

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0.19
0
0
0
0.04
0
0.03
0.01
0.05
0
0.02
42.7
0.04
Operating Profit
-0.19
0
0
0
-0.04
0
-0.03
-0.01
-0.05
0
-0.02
-42.7
-0.04
Other Income
0
0
0
0
0
0
0
-0.5
0
0
0
-12.69
0
Interest
0
0
0
0
0
0
0
0
0
0
0.04
0.22
1.06
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.19
0
0
0
-0.04
0
-0.03
-0.51
-0.05
0
-0.06
-55.61
-1.1
Tax %
0%
—
—
—
0%
—
0%
0%
0%
—
0%
0%
0%
Net Profit
-0.19
0
0
0
-0.04
0
-0.03
-0.51
-0.05
0
-0.06
-55.61
-1.1
EPS (₹)
0
0
0
0
0
0
0
-0.01
0
0
0
-1.01
-0.02
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
1
0
1
3
3
0
0
0
0
Expenses
0
0
0
0
1
0
1
3
2
0
0
43
43
Operating Profit
0
0
0
0
0
0
0
0
0
0
0
-43
-43
OPM %
—
—
—
—
-1.1%
—
0%
4%
9%
—
—
—
—
Other Income
0
0
0
0
0
0
0
0
-2
0
0
-13
-13
Interest
0
0
0
0
0
0
0
0
0
0
0
0
1
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
-1
0
-1
-56
-57
Tax %
0%
0%
0%
0%
0%
0%
—
31%
-3%
0%
0%
0%
—
Net Profit
0
0
0
0
0
0
0
0
-1
0
-1
-56
-57
EPS (₹)
0
0
0
0
0
0
0
0
-0.02
0
-0.01
-1.01
-1.03
Div. Payout %
0%
0%
0%
0%
0%
0%
—
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
50
50
50
50
50
50
50
55
55
55
55
55
Reserves
8
8
8
8
8
8
8
3
2
2
1
-55
Borrowings
1
1
1
2
2
1
1
1
2
2
1
21
Other Liabilities
0
0
0
0
0
0
1
1
1
1
1
0
Total Liabilities
60
59
59
60
60
59
59
60
60
60
58
22
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
54
43
54
54
53
52
52
54
46
46
42
20
Other Assets
6
16
5
6
7
7
7
6
14
14
16
2
Total Assets
60
59
59
60
60
59
59
60
60
60
58
22
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
8
-11
11
-1
-1
0
0
5
0
0
-2
-57
Investing
10
11
-11
0
1
1
0
-5
-1
0
3
58
Financing
2
0
0
1
0
-1
0
0
1
0
-1
0
Net Cash Flow
21
0
0
0
0
0
0
0
0
0
0
0
Free Cash Flow
8
-11
11
-1
-1
0
0
5
0
0
-2
-57
CFO/OP
-41,350
8,385
-8,200
1,417
9,300
-189
—
3,800
-200
25
764
134
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
365
—
807
118
0
—
—
—
Inventory Days
—
—
—
—
—
—
0
0
0
—
—
—
Cash Conversion Cycle
—
—
—
—
365
—
807
118
0
—
—
—
Working Capital Days
—
—
—
—
1,932
—
2,267
-9
-141
—
—
—
ROCE %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-105%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Johnson Pharmacare insights

62 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Public85.56%Others14.44%As ofJun 2026

Documents

Frequently Asked Questions about Johnson Pharmacare

What does Johnson Pharmacare Ltd do?
Johnson Pharmacare Limited, formerly Sun and Shine Worldwide Limited, is an investment-focused listed company with no demonstrated pharmaceutical operations.
Where is Johnson Pharmacare Ltd (JOHNPHARMA) listed?
Johnson Pharmacare Ltd trades under code 532154 on the BSE.
Which sector does Johnson Pharmacare Ltd belong to?
Johnson Pharmacare Ltd is classified under the Commercial Services sector, in the Diversified Services industry.
What is the market capitalisation of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd has a market capitalisation of ₹22.05 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Johnson Pharmacare Ltd?
Over the last 52 weeks Johnson Pharmacare Ltd has traded between ₹0.37 and ₹0.7 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd reported a return on equity of -1.04%. Its debt-to-equity ratio is 0.02.

Company Information

Johnson Pharmacare Limited, formerly Sun and Shine Worldwide Limited, is an investment-focused listed company with no demonstrated pharmaceutical operations.

Website sunandshineworldwidetradelimited.in
Face Value ₹ 1
Shares Outstanding 55,12,82,051

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532154.md for Johnson Pharmacare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Commercial Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month